The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGrit Inv Tst Regulatory News (GRIT)

  • This share is currently suspended. It was suspended at a price of 1.25

Share Price Information for Grit Inv Tst (GRIT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.25
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.25
GRIT Live PriceLast checked at -
Global Resources is an Investment Trust

To generate medium and long-term capital growth through investing in a diverse portfolio of companies which focus on natural resources and mining, primarily listed/quoted on a relevant exchange.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

20 Sep 2023 07:00

RNS Number : 9836M
GRIT Investment Trust PLC
19 September 2023
 

GRIT Investment Trust plc

'GRIT' or 'the Company'

Half-year results for the six months ended 30 June 2023

Chairman's statement

The last six months have seen a continued increase in interest rates and high inflation in the UK. The economic uncertainties in global capital markets largely associated with the Russia-Ukraine conflict, have continued. However, this challenging economic background has presented a number of opportunities to the Company's board in its pursuit of a suitable reverse takeover target.

 

Set out below is the interim statement covering the six months ended 30 June 2023. A loss of £83,000 is being reported for the six months ended 30 June 2023 compared to a loss of £89,000 for the six months ended 30 June 2022. The board continues to manage costs carefully in an effort to preserve shareholder value.

 

Salient events

 

Completion of Creditors Voluntary Arrangement 

 

In May 2023 the Company announced that the Creditors Voluntary Arrangement ("CVA") was successfully completed following the approval of the Company's variation to creditors to bring the CVA to an early conclusion. The CVA creditors received a total of 83.06p in the £1, which compared favourably to the 20p in the £1 in the original CVA proposal. The completion of the CVA is an important step forward for the Company which can now plan a future free of its historical debts.

 

 

Share Capital Reorganisation and Conversion of the outstanding CULNs

 

A share capital reorganisation was approved at the Company's AGM in June resulting in each existing ordinary share of 2.5p be sub-divided into one ordinary share of 0.1p and one deferred share of 2.4p. Resolutions were also passed at the AGM to enable the Company to issue 11,472,175 New Ordinary Shares in connection with the conversion of the outstanding CULN's and issue up to an additional 120,000,000 New Ordinary Shares for cash.

 

 

Strategy of the new Board

 

Whilst the Company is still an Investment Trust, it continues to seek to acquire a business which would result in a Reverse Takeover. This will enable the Company to achieve an appropriate listing on a public market and it is envisaged that the announcement of any such proposed transaction would result in the suspension of the Company's shares from trading on the Official List. If an RTO transaction can be achieved the Board believes it will provide a platform for the future growth of the Company and a positive outcome for shareholders. 

 

 

 

 

 

 

 

Richard Lockwood

 

Chairman

20 September 2023


Enquiries:

GRIT Investment Trust plc

Martin Lampshire

Tel: +44 (0)20 3198 2554

 

Peterhouse Capital Limited

Lucy Williams/Duncan Vasey

Tel: +44 (0)20 7469 0930


 

Income Statement

Revenue

Capital

Total

Unaudited

Unaudited

Unaudited

Notes

£'000

£'000

£'000

Six months ended 30 June 2023

 

Profit on disposal of investments

-

-

-

Other income

-

-

-

Other expenses

(83)

-

(83)

Net return before finance costs and taxation

(83)

-

(83)

Interest payable and similar charges

-

-

-

Net return on ordinary activities before taxation

(83)

-

(83)

Tax on ordinary activities

-

-

-

Net return attributable to equity shareholders

(83)

-

(83)

 

 

 

Profit (loss) per ordinary share

3

(0.52p)

-

(0.52p)

 

 

Six months ended 30 June 2022

 

Profit on disposal of investments

-

-

-

Other income

96

-

96

Other expenses

(153)

-

(153)

Net return before finance costs and taxation

(57)

-

(57)

Interest payable and similar charges

(32)

-

(32)

Net return on ordinary activities before taxation

(89)

-

(89)

Tax on ordinary activities

-

-

-

Net return attributable to equity shareholders

(89)

 

(89)

 

 

 

Profit (loss) per ordinary share

3

(0.56p)

-

(0.56p)

 

 

Year ended 31 December 2022

 

Profit on disposal of investments

-

-

-

Other income

96

-

96

Other expenses

(212)

-

(212)

Net return before finance costs and taxation

(116)

-

(116)

Interest payable and similar charges

(39)

-

(39)

Net return on ordinary activities before taxation

(155)

-

(155)

Tax on ordinary activities

-

-

-

Net return attributable to equity shareholders

(155)

-

(155)

 

 

 

 

Profit (loss) per ordinary share

3

(2.35p)

-

(2.35p)

 

The 'total' column of this statement represents the Company's profit and loss account, prepared in accordance with IFRS. All revenue and capital items in this statement derive from continuing operations. All of the profit for the period is attributable to the owners of the Company.

No operations were acquired or discontinued in the year.

A Statement of Other Comprehensive Income is not required as all gains and losses of the Company have been reflected in the above Income Statement.

 

Balance Sheet

As at 30 June 2023

As at 31 December 2022

As at 30 June 2022

Unaudited

Audited

Unaudited

Notes

£'000

£'000

£'000

Fixed assets

 

 

 

Investments

-

-

-

-

-

-

Current assets

Debtors

24

140

137

Cash at bank and on deposit

19

66

187

43

206

324

Creditors: amounts falling due within one year

Other creditors

(107)

(271)

(330)

Convertible unsecured loan notes

(370)

-

-

Net current (liabilities) assets

(434)

(65)

(6)

Creditors: amounts falling due after one year

Convertible unsecured loan notes

-

(445)

(692)

Net (liabilities) assets

(434)

(510)

(698)

Capital and reserves

Called up share capital

833

758

504

Share premium

36,922

36,922

36,922

Capital reserve

(32,697)

(32,697)

(32,697)

Revenue reserve

(5,560)

(5,561)

(5,495)

Other reserve

68

68

68

Equity shareholders' funds

(434)

(510)

(698)

 

 

 

Net asset value per share

4

(2.38p)

(3.36p)

(13.86p)

 

 

Statement of Changes in Equity

Share capital

Share premium account

Capital reserve

Revenue reserve

Other reserve

Total

 

£'000

£'000

£'000

£'000

£'000

£'000

 

For the 6 months to 30 June 2023 (unaudited)

 

 

Balance at 31 December 2022

758

36,922

(32,697)

(5,561)

68

(510)

 

Issue of shares

75

-

-

-

-

75

 

Return on ordinary activities after taxation

-

-

-

1

-

1

 

Balance at 30 June 2023

833

36,922

(32,697)

(5,560)

68

(434)

 

 

For the 6 months to 30 June 2022 (unaudited)

Balance at 31 December 2021

504

36,922

(32,697)

(5,406)

68

(609)

 

Issue of shares

-

-

-

-

-

-

 

Return on ordinary activities after taxation

-

-

-

(89)

-

(89)

 

Balance at 30 June 2022

504

36,922

(32,697)

(5,495)

68

(698)

 

The revenue reserve represents the amount of the Company's reserves distributable by way of dividend.

Cash Flow Statement

 

Six months ended 30 June

 

2023

2022

Unaudited

Unaudited

£'000

£'000

 

 

 

 

(Loss)/profit before finance costs and taxation

(83)

(57)

 

Adjustments for:

Conclusion of Company Voluntary Arrangement

84

-

Operating cash flows before movements in working capital

1

(57)

 

Operating activities

(Increase)/Decrease in other receivables

116

(137)

(Decrease)/increase in other payables

(164)

(107)

Net cash outflow from operating activities

(47)

(301)

Investing activities

Proceeds from the sale of investment

-

-

Net cash inflow from investing activities

-

-

 

Financing activities

Issue of shares

-

-

Net cash inflow from financing activities

-

 -

 

Increase/(decrease) in cash and cash equivalents

(47)

(301)

Net cash at the start of the period

66

488

Net cash at the end of the period

19

187

 

The accompanying notes are an integral part of the financial statements.

 

Notes

1. Interim Results

These condensed financial statements have been prepared in accordance with International Financial Reporting Standards ('IFRS') and IAS 34 'Interim Financial Reporting' as adopted by the UK and the accounting policies set out in the statutory accounts of the Company for the year ended 31 December 2022. The condensed financial statements do not include all of the information required for a complete set of IFRS financial statements and should be read in conjunction with the financial statements of the Company for the year ended 31 December 2022, which were prepared in accordance with UK-adopted international accounting standards. There have been no significant changes to management judgements and estimates.

2. Going Concern Basis of Accounting

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

3. Return per Ordinary Share

The revenue loss per ordinary share for the six months ended 30 June 2023 is based on a net loss after taxation of £83,000 and on a weighted average of 15,838,260 ordinary shares in issue during the period.

The capital loss per ordinary share for the six months ended 30 June 2023 is based on a net capital profit after taxation of £Nil and on a weighted average of 15,838,260 ordinary shares in issue during the period.

4. Net Asset Value per Ordinary Share

The net asset value per ordinary share is based on net liabilities of £434,000 (31 December 2022: net liabilities of £510,000) and on 18,198,295 (31 December 2022: 15,196,857) ordinary shares, being the number of ordinary shares in issue at the period end.

5. Related Party Transactions

The Board of Directors is considered to be a related party. The Directors of the Company received fees for their services. Total fees for the six months to 30 June 2023 were £Nil (six months ended 30 June 2022: £10,000) At 30 June 2023 directors were owed £Nil (30 June 2022: £60,370).

5. Post Balance Sheet Events

Events since the balance sheet date are fully described in the outgoing Chairman's statement.

 

Interim Report Statement

The Company's auditor PKF Littlejohn LLP, has not audited or reviewed the Interim Report to 30 June 2023 pursuant to the Auditing Practices Board guidance on 'Review of Interim Financial Information'. These are not full statutory accounts in terms of Section 434 of the Companies Act 2006 and are unaudited. Statutory accounts for the year ended 31 December 2022, which received an unqualified audit report and which did not contain a statement under Section 498 of the Companies Act 2006, have been lodged with the Registrar of Companies. No full statutory accounts in respect of any period after 31 December 2022 have been reported on by the Company's auditor or delivered to the Registrar of Companies.

Directors' Statement of Principal Risks and Uncertainties

The risks, and the way in which they are managed, are described in more detail in the Strategic Report contained within the Annual Report and Financial Statements for the year ended 31 December 2022. In the opinion of the Directors the Company's principal risks and uncertainties have not changed materially since the date of that report and did not change materially for the rest of the Company's financial reporting period to 31 December 2022.

Statement of Directors' Responsibilities in Respect of the Interim Report

We confirm that to the best of our knowledge:

· the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting' and gives a true and fair view of the assets, liabilities, financial position and loss of the Company;

 

· the Chairman's Statement and Executive Director's Review (together constituting the Interim Management Report) include a fair review of the information required by the Disclosure Guidance and Transparency Rules ('DTR') 4.2.7R, being an indication of important events that have occurred during the first six months of the year and their impact on the financial statements; and

 

· other than directors' remuneration, there have been no related party transactions that materially affected the financial position or performance of the Company during the period.

On behalf of the Board

 

 

 

Richard Lockwood

Chairman

20 September 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BCGDCBGBDGXC
Date   Source Headline
26th Apr 20247:00 amRNSChange to Accounting Reference Date
20th Mar 20247:49 amRNSTemporary Suspension of listing
25th Jan 202410:52 amRNSHolding(s) in Company
25th Jan 20247:00 amRNSCapital Reorganisation - update
24th Jan 20241:58 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSHalf-year Report
7th Jul 202312:46 pmRNSResult of AGM
12th Jun 20235:27 pmRNSNotice of AGM
31st May 202311:50 amRNSHolding(s) in Company
25th May 20231:35 pmRNSCompletion of CVA
28th Apr 20237:00 amRNSFinal Results
19th Apr 202312:58 pmRNSHolding(s) in Company
6th Apr 202312:52 pmRNSConversion of Loan Notes and TVR
9th Jan 20235:41 pmRNSHolding(s) in Company
5th Jan 20231:07 pmRNSHolding(s) in Company
15th Dec 20224:04 pmRNSHolding(s) in Company
7th Dec 20223:29 pmRNSHolding(s) in Company
23rd Nov 202212:53 pmRNSDirector/PDMR Shareholding
21st Nov 20221:47 pmRNSDirector/PDMR Shareholding
16th Nov 20221:16 pmRNSLoan Note Conversion, PDMR Director Dealing, TVR
15th Nov 20223:22 pmRNSLoan Note Conversion, PDMR/Director Dealing, TVR
11th Nov 20226:23 pmRNSTotal Voting Rights
2nd Nov 202211:05 amRNSHolding(s) in Company
31st Oct 20227:00 amRNSPDMR Dealings
28th Oct 20223:23 pmRNSHolding(s) in Company
28th Oct 20222:22 pmRNSPDMR Dealings
27th Oct 20223:51 pmRNSPDMR Dealings
26th Oct 202211:59 amRNSConversion of Existing Convertible Loan Notes
25th Oct 202211:12 amRNSConversion of Existing Convertible Loan Notes
24th Oct 202211:31 amRNSConversion of Existing Convertible Loan Notes
30th Sep 20227:00 amRNSHalf-year Report
23rd Sep 20222:59 pmRNSHolding(s) in Company
16th Sep 20222:53 pmRNSStrategy Update
8th Sep 20229:35 amRNSHolding(s) in Company
29th Jul 20224:22 pmRNSCLNs Final Redemption Date Extension
8th Jul 20223:06 pmRNSHolding(s) in Company
30th Jun 20225:14 pmRNSResult of AGM
30th Jun 20223:47 pmRNSAnnual Financial Report
29th Jun 202212:38 pmRNSHolding(s) in Company
17th Jun 20221:17 pmRNSHolding(s) in Company
7th Jun 20226:18 pmRNSNotice of AGM
16th May 20225:26 pmRNSHolding(s) in Company
28th Feb 20222:16 pmRNSHolding(s) in Company
25th Feb 202212:12 pmRNSResult of AGM
24th Feb 20227:00 amRNSAnnual General Meeting Update
22nd Feb 20225:21 pmRNSTotal Voting Rights
2nd Feb 20229:35 amRNSReplacement: Notice of AGM
1st Feb 20222:48 pmRNSNotice of AGM
12th Jan 20227:17 amRNSChange of Name
7th Jan 20221:50 pmRNSResult of Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.